Pharma Articles - Insights & Trends | World Pharma Today

eschbach Launches New Digital Leader Standard Work Capability for Pharma Process Operations

Yuvraj — Mon, 05 Oct 2026 11:20:47 +0000

Seqonis Intelligent Operations by eschbach has a new dedicated capability called Leader Standard Work capability, which empowers pharmaceutical organizations to bring leadership routine planning, execution, documentation and evaluation into a single digital workflow. What does this mean for pharmaceutical manufacturers operating in highly regulated environments? Leadership activities can now be performed consistently as well as […]

The post eschbach Launches New Digital Leader Standard Work Capability for Pharma Process Operations first appeared on World Pharma Today.

Where nasal drug development goes wrong, and how to get ahead of it

Yuvraj — Sat, 03 Oct 2026 07:39:12 +0000

Nasal delivery is attracting interest for both systemic therapies and drugs targeting the central nervous system (CNS). The nasal mucosa offers a route to systemic absorption that avoids first-pass metabolism, while delivery via the olfactory and trigeminal pathways is being explored as a way to reach the CNS. But a promising molecule and formulation are […]

The post Where nasal drug development goes wrong, and how to get ahead of it first appeared on World Pharma Today.

Obesity Drugs 2.0: The Race for More Powerful, Convenient and Next-Generation Weight-Loss Medicines

Yuvraj — Sat, 19 Sep 2026 06:45:52 +0000

Obesity treatment is entering a more competitive phase. Ozempic and Mounjaro helped make GLP-1-based medicines mainstream, but the next wave is looking beyond simply producing weight loss. The opportunity is significant because obesity remains widespread. U.S. data show that 40.3% of adults had obesity in 2021–2023, while 9.7% had severe obesity. Towards Healthcare Research and […]

The post Obesity Drugs 2.0: The Race for More Powerful, Convenient and Next-Generation Weight-Loss Medicines first appeared on World Pharma Today.

Beyond Market Access: Operational Regulatory Readiness Has Become the Real Gateway to Europe’s Pharmaceutical Market

Yuvraj — Mon, 07 Sep 2026 13:01:56 +0000

Over the past two decades, the global pharmaceutical industry’s geography has changed profoundly: India’s pharmaceutical sector has evolved from a low-cost manufacturing base into a globally competitive industry capable of supplying regulated markets. China remains structurally critical, above all for APIs and key starting materials. South Korea is moving rapidly up the pharmaceutical value chain, […]

The post Beyond Market Access: Operational Regulatory Readiness Has Become the Real Gateway to Europe’s Pharmaceutical Market first appeared on World Pharma Today.

Why the fastest route to low-GWP pMDIs requires more than a new propellant

Yuvraj — Thu, 27 Aug 2026 10:02:56 +0000

Opinion by Darren Bromley-Davenport, Technical Manager at Orbia Fluor & Energy Materials The transition to low-global warming potential (GWP) pressurised metered-dose inhalers (pMDIs) is now well underway. In recent years, significant progress has been made in identifying alternative propellants capable of reducing the environmental impact of pMDIs while maintaining the performance patients rely on. Among […]

The post Why the fastest route to low-GWP pMDIs requires more than a new propellant first appeared on World Pharma Today.

Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery

Yuvraj — Mon, 17 Aug 2026 07:18:26 +0000

When DeciBio asked nine senior pharma executives what was holding back AI adoption in R&D, the answer wasn’t algorithms or compute. Three of the top four barriers they named were data problems, and low-quality data was cited by every single one of them. Every AI drug discovery pitch deck has a slide about proprietary data. […]

The post Why More Data Doesn’t Automatically Mean Better AI in Drug Discovery first appeared on World Pharma Today.

Beyond the Purity Percentage

Yuvraj — Thu, 06 Aug 2026 08:06:15 +0000

How pharmaceutical and life-science R&D teams can qualify high-purity specialty inorganic salts using rubidium chloride and rubidium carbonate to illustrate the importance of impurity profiles, analytical evidence, packaging and supplier consistency. Rubidium Carbonate Rubidium Chloride Qualification at a glance Focus: Impurity profile, evidence, consistency and control Use cases: Pharma, life science, diagnostics and formulation R&D […]

The post Beyond the Purity Percentage first appeared on World Pharma Today.

The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients

Yuvraj — Fri, 12 Jun 2026 09:57:32 +0000

How advanced analytical methods, potency assays, and immune profiling are shaping the future of cancer cell therapies Cell therapies have transformed the treatment landscape for patients with cancer and other serious diseases. Innovations such as CAR-T cell therapies have demonstrated remarkable clinical success, offering new treatment options for patients with limited alternatives. While much of […]

The post The Engine of Cell Therapy Success: Why Analytical Development Determines Whether Promising Cell Therapies Reach Patients first appeared on World Pharma Today.

Stevanato Group and Syntegon Join Forces to Drive Innovation

Yuvraj — Tue, 02 Jun 2026 13:27:06 +0000

Quality first: advanced manufacturing process for EZ-fill® cartridges The development of GLP-1 drugs has revolutionized the treatment of diabetes and obesity – and is a catalyst for breaking new grounds in ready-to-use cartridge manufacturing. Primary packaging provider Stevanato Group has teamed up with equipment supplier Syntegon to develop an advanced manufacturing process for Stevanato Group’s […]

The post Stevanato Group and Syntegon Join Forces to Drive Innovation first appeared on World Pharma Today.

Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance

Yuvraj — Thu, 07 May 2026 12:00:58 +0000

As life sciences supply chains become more volatile, real-time visibility is increasingly the baseline for operational excellence. The next frontier is orchestration: turning fragmented signals into decisions that prevent excursions, reduce waste, and protect patients. Sam Durham, Product Manager – Digital Solutions & Services at Cold Chain Technologies, explains the role of digital technology in […]

The post Move Beyond Visibility: Why Cold Chain Orchestration is Now Essential for Thermal Assurance first appeared on World Pharma Today.